Prevalence, risk factors and molecular epidemiology of neonatal cryptosporidiosis of calves : The Argentine perspective
Cryptosporidium spp. are enteroparasitic protozoans that cause cryptosporidiosis in newborn calves. Clinical signs of the infection are diarrhoea and dehydration leading to decreased productivity and economic losses in cattle farms around the world. Additionally, cryptosporidiosis is a relevant zoon...
| Autores principales: | , , , |
|---|---|
| Formato: | info:ar-repo/semantics/artículo |
| Lenguaje: | Inglés |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12123/16119 https://www.sciencedirect.com/science/article/pii/S2667114X23000353 https://doi.org/10.1016/j.crpvbd.2023.100147 |
Ejemplares similares: Prevalence, risk factors and molecular epidemiology of neonatal cryptosporidiosis of calves : The Argentine perspective
- Infección experimental con Cryptosporidium parvum en terneros neonatos: dinámica clínica y parasitaria = Experimental infection with Cryptosporidium parvum in neonatal calves: clinical and parasitic dynamics
- P23-Specific IgY significantly reduces diarrhea and oocyst shedding in calves experimentally infected with Cryptosporidium parvum
- Prevalence of Cryptosporidium parvum in dairy calves and GP60 subtyping of diarrheic calves in central Argentina
- Estudio retrospectivo de multirresistencia antimicrobiana en aislamientos de Escherichia coli de terneros con diarrea neonatal = Retrospective study of multiple antimicrobial resistance in Escherichia coli isolates from neonatal calves with diarrhea
- Expresión heteróloga y purificación de la proteína antigénica de superficie CpSUB2 de Cryptosporidium parvum para formulaciones vacunales = Heterologous expression and purification of the antigenic surface protein CpSUB2 from Cryptosporidium parvum for vaccine formulations
- Controlling Rotavirus-associated diarrhea: Could single-domain antibody fragments make the difference? = Hacia el control de la diarrea por rotavirus A: ¿podrían los nanoanticuerpos VHH marcar la diferencia?